Evidence map›Paper›PMID 12196630›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Regulation of V(D)J recombination: a dominant role for promoter positioning in gene segment accessibility.

Michael L Sikes, Amber Meade, Rajkamal Tripathi, Michael S Krangel, Eugene M Oltz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The center of accessibility: Dβ control of V(D)J recombination.Archivum immunologiae et therapiae experimentalis · 2010
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael L SikesDepartment of Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232, USA.
Amber Meade
Rajkamal Tripathi
Michael S Krangel
Eugene M Oltz
Duke Medical Center · USDuke University Hospital · USVanderbilt University Medical Center · US

Funding

CONTROL OF TCR V BETA REARRANGEMENT &ALLELIC EXCLUSIONR01AI049934 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2001 to 2015
$6.8M
Control Of Tcr Delta And Tcr Alpha RearrangementR37GM041052 · NIGMS · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2006 to 2015
$5.1M
HUMAN GAMMA DELTA T CELL RECEPTORR01GM041052 · NIGMS · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 1989 to 2019
$4.8M
NIAID NIH HHS AI01412NIAID NIH HHS AI37944NIAID NIH HHS AI49934NIAID NIH HHS R01 AI049934NIGMS NIH HHS GM41052NIGMS NIH HHS R01 GM041052NIGMS NIH HHS R37 GM041052
6 · The paper itself

Abstract

Antigen receptor gene assembly is regulated by transcriptional promoters and enhancers, which control the accessibility of gene segments to a lymphocyte-specific V(D)J recombinase. However, it remained unclear whether accessibility depends on the process of transcription itself or chromatin modifications that accompany transcription. By using T cell receptor beta substrates that integrate stably into nuclear chromatin, we show that promoter location, rather than germ-line transcription or histone acetylation, is a primary determinant of recombination efficiency. These spatial constraints on promoter positioning may reflect an RNA polymerase-independent mechanism to target adjacent gene segments for chromatin remodeling events that facilitate rearrangement.

Indexed as

Genes, ImmunoglobulinPromoter Regions, GeneticRecombination, GeneticAcetylationCell LineDNA-Binding ProteinsDNA NucleotidyltransferasesGenes, RAG-1HistonesHomeodomain ProteinsHumansLymphocytesModels, GeneticNuclear ProteinsReceptors, Antigen, T-Cell, alpha-betaTransfectionDNA-Binding ProteinsDNA NucleotidyltransferasesHistonesHomeodomain ProteinsNuclear ProteinsRAG-1 proteinRAG2 protein, humanReceptors, Antigen, T-Cell, alpha-betaVDJ RecombinasesV(D)J recombination activating protein 2

Identifiers

PMID12196630
PMCPMC129441
OpenAlexW2070743892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.